Orientations

Interim recommendations for the use of the Janssen Ad26.COV2.S (‎COVID-19)‎ vaccine: interim guidance

World Health Organization (WHO)

These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.

This document has been updated: Version 9 December 2021.

Auteurs

Langues

  • Anglais

Année de publication

2021

Type

Orientations

Catégories

  • Vaccins et dispositifs d'administration

Maladies

  • COVID-19

Ajouté par: Géraldine Nemrod

Ajouté le: 2021-03-21 02:44:48

Consultations: 840

Liens

Ajouter une ressource